Antibiotic resistance

Antibiotics be responsible Each year, 30 EU/EEA countries report data on antimicrobial resistance to the European Antimicrobial Resistance Surveillance Network (EARS-Net) and on antimicrobial consumption to the European Surveillance of Antimicrobial Consumption network (ESAC-Net). Both networks are hosted at ECDC. The emergence and spread of antibiotic resistance, in other words the ability of bacteria to resist the action of an antibiotic, has become a recognised global problem. Antibiotic resistance severely limits the number of antibiotics available for the treatment of diseases. Antibiotic resistance Resistance occurs naturally and is developed through selective pressure, mutation and gene transfer. Each year, about 25 000 patients die in the EU from an infection Streptococcus pneumoniae Consequences for hospital patients include delayed administration of appropriate antibiotic therapy, longer length of stay, higher healthcare costs and poor patient caused by these drug-resistant bacteria. 8.7 Resistance outcomes. Infections due to these multidrug-resistant bacteria in the EU result in extra healthcare costs each year of at least: Staphylococcus aureus Escherichia coli €1500 000 000 17.8 Resistance 57.4 Resistance Pseudomonas aeruginosa Enterococcus faecalis -- . Klebsiella pneumoniae 26.5% Resistance 21 Resistance 25.7. Resistance